Gevo (GEVO) is drawing fresh attention after appointing Todd Werpy, a long-tenured leader in sustainable technologies and biotechnology, to its Board of Directors, alongside interest around the upcoming second quarter 2026 earnings call.

Gevo’s share price has climbed in recent weeks, with a 30 day share price return of 30.71% and a 7 day move of 15.09%. Year to date, however, the share price return is down 11.16%, while the 1 year total shareholder return of 22.00% points to stronger gains for longer term holders.

If you are looking to widen your search beyond Gevo and into other potential opportunities tied to the energy transition, take a look at the 90 nuclear energy infrastructure stocks

Gevo’s business is gaining attention in low carbon fuels, but after a sharp short term share price move and a wide gap to analyst price targets, investors may question whether the current valuation still offers an appealing entry point or whether it has run ahead of itself.

Most Popular Narrative: 65.6% Undervalued

Gevo’s most followed narrative pegs fair value at $5.33, well above the last close at $1.83, which frames a sizable valuation gap for investors to consider.

Monetization and growth of high integrity carbon dioxide removal (CDR) credits and clean fuel production tax credits (CFPCs), enabled by Gevo's uniquely certified carbon sequestration site, provide new stable, high margin revenue streams and cost offsets that are expected to meaningfully lift recurring net income and reduce volatility.

Want to see what underpins that valuation gap for Gevo? The narrative leans heavily on a mix of revenue growth, margin expansion, and richer future earnings multiples. Curious which of those levers does the heaviest lifting in the model and how sensitive the story is to even small changes in those assumptions? The full narrative sets out those moving parts in detail so you can compare them with your own view.

Result: Fair Value of $5.33 (UNDERVALUED)

However, the Gevo narrative still carries clear risks, including heavy dependence on government tax credits and the large, long dated capital projects needed to scale its fuels and carbon businesses.

Another View on Gevo’s Valuation

While the Gevo narrative points to a large gap between fair value at $5.33 and the current $1.83 share price, the market is also signaling a different message. On a P/S ratio of 2.5x, Gevo screens as expensive versus both peers at 1x and the US Oil and Gas industry at 2.1x, and even above an estimated fair ratio of 1.3x. That higher multiple can suggest investors are already paying up for future growth. The key question is whether your own expectations justify leaning into that valuation risk.

Next Steps

If the mixed sentiment around Gevo has you thinking, this is a good moment to dig into the details and stress test your own thesis using the 3 key rewards

Looking for more investment ideas beyond Gevo?

If Gevo has sharpened your thinking, do not stop there. Use the Simply Wall Street Screener to line up fresh investment ideas that fit your style.

• Target potential mispricing by checking stocks that appear attractively valued on fundamental checks through the 38 high quality undervalued stocks.
• Strengthen your focus on capital preservation by reviewing companies with resilient finances via the 79 resilient stocks with low risk scores.
• Spot future contenders early by scanning quality businesses that still fly under the radar using the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.